JOHN MANALOOR to Adolescent
This is a "connection" page, showing publications JOHN MANALOOR has written about Adolescent.
Connection Strength
0.093
-
Susceptibility Provision Enhances Effective De-escalation (SPEED): utilizing rapid phenotypic susceptibility testing in Gram-negative bloodstream infections and its potential clinical impact. J Antimicrob Chemother. 2019 01 01; 74(Suppl 1):i16-i23.
Score: 0.041
-
Assessing the Diagnostic Performance and Clinical Utility of Nasal Methicillin-Resistant Staphylococcus aureus PCR Testing in Pediatric Orbital Cellulitis. J Pediatric Infect Dis Soc. 2024 Aug 24; 13(8):430-433.
Score: 0.015
-
Comparison of Risk of Recrudescent Fever in Children With Kawasaki Disease Treated With Intravenous Immunoglobulin and Low-Dose vs High-Dose Aspirin. JAMA Netw Open. 2020 01 03; 3(1):e1918565.
Score: 0.011
-
The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease. Contemp Clin Trials. 2019 04; 79:98-103.
Score: 0.010
-
Success With Extended-Infusion Meropenem After Recurrence of Baclofen Pump-Related Achromobacter Xylosoxidans Meningitis in an Adolescent. J Pharm Pract. 2015 Aug; 28(4):430-3.
Score: 0.008
-
Travel-related infections in children. Pediatr Clin North Am. 2013 Apr; 60(2):507-27.
Score: 0.007